CD8A and neoplasm: Although IL-10 is usually considered an immunosuppressive cytokine and higher IL-10 expression correlates with tumor progression, a recent study provided compelling evidence that an engineered interleukin-10–Fc fusion protein may act through metabolic rewiring to enhance the effector functions of terminally exhausted CD8 T cells [46].